Compliance Beyond the Mock Audit
Uncover Detailed Program Intelligence
Rx|X has developed a proprietary audit tool, Avanti340B, to oversee the data connections and team processes that power procurement and inventory management of 340B drugs. Avanti340B allows teams to go beyond patient transaction testing and provides insights into issues that can cloud the performance of split-billing software.Clients can subscribe to quarterly use of the top, managed by Rx|X experts. Gain enhanced program visibility and turn results into actions to improve mapping, unit conversions, billing units and buyer processes. Reimplementing or changing split-billing vendors? Have a manufacturer good-faith inquiry on purchasing? Avanti340B is your tool to unlocking deeper analytical views.
A Complete View of your Program’s Purpose
Rx|X helps covered entities modernize their 340B programs to stay strong advocates for today’s healthcare safety net. 340B/360© is our proprietary framework designed to assess how effectively your organization’s 340B program supports its mission — and the communities it serves.Built from over 25 years of experience, 340B/360© looks at your program from every angle: data, structure, strategy, and impact. Through targeted data review, interviews, and on-site collaboration, Rx|X identifies opportunities to strengthen compliance and align operations with your organization’s goals.
The result? A clear, actionable roadmap for 340B program excellence — from current-state evaluation to implementation of tailored recommendations and stronger program organization.
340B/360© gives you the clarity, confidence, and strategy to ensure your 340B program isn’t just compliant — it’s transformative.
Medicaid Billing Compliance Audit
A new service designed to give 340B hospitals confidence in their Medicaid claims integrity. Our audit goes beyond traditional 340B reviews to assess the accuracy, consistency, and defensibility of Medicaid billing practices. Rx|X’s team evaluates whether claims reflect actual acquisition cost (AAC) where required, verifies appropriate use of modifiers and submission codes, and confirms that billing aligns with both state-specific rules and HRSA guidance. We also conduct a detailed Medicaid claims review that mirrors HRSA audit procedures—testing alignment with the Medicaid Exclusion File (MEF) and validating covered entity and contract pharmacy NPI configurations. With this new offering, Rx|X helps clients identify vulnerabilities before they become audit findings, ensuring that every claim reflects compliance, accuracy, and accountability.